These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 3879563)
1. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin. Tanaka M; Kimura K Tohoku J Exp Med; 1985 Dec; 147(4):331-41. PubMed ID: 3879563 [TBL] [Abstract][Full Text] [Related]
2. The effect of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells. Sylwestrowicz T; Piga A; Murphy P; Ganeshaguru K; Russell NH; Prentice HG; Hoffbrand AV Br J Haematol; 1982 Aug; 51(4):623-30. PubMed ID: 6980665 [TBL] [Abstract][Full Text] [Related]
3. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response. Ho AD; Ganeshaguru K; Knauf W; Dietz G; Trede I; Hoffbrand AV; Hunstein W Leuk Res; 1989; 13(4):269-78. PubMed ID: 2785618 [TBL] [Abstract][Full Text] [Related]
4. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro. Begleiter A; Pugh L; Israels LG; Johnston JB Cancer Res; 1988 Jul; 48(14):3981-6. PubMed ID: 3260129 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase. Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047 [TBL] [Abstract][Full Text] [Related]
6. Toxicity and immunosuppressive activity of binary combinations of 2'-deoxycoformycin and 2'-deoxyadenosine. Paine RM; Weston BJ; Clink HM; Kohn J; Neville AM; McGhee KG; Harrap KR Cancer Treat Rep; 1981; 65(3-4):259-66. PubMed ID: 6972254 [TBL] [Abstract][Full Text] [Related]
7. Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin. Matsumoto SS; Yu AL; Bleeker LC; Bakay B; Kung FH; Nyhan WL Blood; 1982 Nov; 60(5):1096-102. PubMed ID: 6289941 [TBL] [Abstract][Full Text] [Related]
8. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia. Yu AL; Bakay B; Kung FH; Nyhan WL Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800 [TBL] [Abstract][Full Text] [Related]
9. Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus deoxycoformycin. Matsumoto SS; Yu AL; Yu J Cancer Invest; 1985; 3(3):225-33. PubMed ID: 3873981 [TBL] [Abstract][Full Text] [Related]
10. The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei. Matsumoto SS; Yu J; Yu AL J Biol Chem; 1988 May; 263(15):7153-8. PubMed ID: 3259231 [TBL] [Abstract][Full Text] [Related]
11. Inhibitor of 2',5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon. Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H Biochem Biophys Res Commun; 1985 Mar; 127(3):1019-25. PubMed ID: 3872657 [TBL] [Abstract][Full Text] [Related]
12. The relative sensitivity of peripheral blood T-lymphocyte colony forming cells and bone marrow CFU-GM to deoxyadenosine and 2'deoxycoformycin. Russell NH; Carron J; Hoffbrand AV; Bellingham AJ Leuk Res; 1985; 9(2):315-9. PubMed ID: 3872974 [TBL] [Abstract][Full Text] [Related]
13. Biochemical mechanisms of deoxycoformycin toxicity in chronic leukemias. Ganeshaguru K; Ho AD; Piga A; Catovsky D; Hoffbrand AV Leuk Res; 1987; 11(10):941-5. PubMed ID: 3500370 [TBL] [Abstract][Full Text] [Related]
14. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro. Begleiter A; Glazer RI; Israels LG; Pugh L; Johnston JB Cancer Res; 1987 May; 47(9):2498-503. PubMed ID: 3494509 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes. Matsumoto SS; Yu J; Yu AL J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398 [TBL] [Abstract][Full Text] [Related]
16. Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon. Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H Adv Exp Med Biol; 1986; 195 Pt B():683-7. PubMed ID: 3490130 [No Abstract] [Full Text] [Related]
17. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells. Ruers TJ; Buurman WA; van der Linden CJ J Immunol; 1987 Jan; 138(1):116-22. PubMed ID: 3097141 [TBL] [Abstract][Full Text] [Related]
18. Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin. Schwartz CL; Minniti CP; Harwood P; Na S; Banquerigo ML; Strauss LC; Kurtzberg J; Smith SD; Civin CI J Clin Oncol; 1987 Dec; 5(12):1900-11. PubMed ID: 3500279 [TBL] [Abstract][Full Text] [Related]
19. Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2'-deoxycoformycin and 2'-deoxyadenosine: association with dATP-dependent activation of caspase-3. Niitsu N; Yamaguchi Y; Umeda M; Honma Y Blood; 1998 Nov; 92(9):3368-75. PubMed ID: 9787175 [TBL] [Abstract][Full Text] [Related]
20. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia. Kurtzberg J; Hershfield MS Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]